Lipopolysaccharide attenuates mRNA levels of several adenylyl cyclase isoforms in vivo

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1772, Issue 1, 2007, Pages 32-39

  Risøe, Petter Kirkeby ^a   Wang, Yunyong ^a,b   Stuestøl, Jon Fredrik ^a   Aasen, Ansgar O ^a,b   Wang, Jacob E ^b   Dahle, Maria K ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adenylyl cyclase; cAMP; Endotoxemia; Inflammation; Lipopolysaccharide

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTOXEMIA; HEART; INFLAMMATION; KIDNEY; KUPFFER CELL; LIVER; LUNG; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SPLEEN; STATISTICAL ANALYSIS;

ADENYLATE CYCLASE; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENDOTOXEMIA; GENE EXPRESSION REGULATION; KUPFFER CELLS; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MALE; ORGAN SPECIFICITY; PROTEIN ISOFORMS; RATS; RATS, WISTAR; RNA, MESSENGER;

ANIMALIA;

EID: 33845665875     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2006.08.007     Document Type: Article

References (57)

1. Moss M., and Martin G.S. A global perspective on the epidemiology of sepsis. Intensive Care Med. 30 (2004) 527
2. Remick D.G., Strieter R.M., Eskandari M.K., Nguyen D.T., Genord M.A., Raiford C.L., and Kunkel S.L. Role of tumor necrosis factor-alpha in lipopolysaccharide-induced pathologic alterations. Am. J. Pathol. 136 (1990) 49
3. Balk R.A., and Bone R.C. The septic syndrome. Definition and clinical implications. Crit. Care Clin. 5 (1989) 1
4. Dasta J.F. Norepinephrine in septic shock: renewed interest in an old drug. DICP 24 (1990) 153
5. Holmes C.L., Patel B.M., Russell J.A., and Walley K.R. Physiology of vasopressin relevant to management of septic shock. Chest 120 (2001) 989
6. Fowler D.E., Yang S., Zhou M., Chaudry I.H., Simms H.H., and Wang P. Adrenomedullin and adrenomedullin binding protein-1: their role in the septic response. J. Surg. Res. 109 (2003) 175
7. Coimbra R., Porcides R.D., Melbostad H., Loomis W., Tobar M., Hoyt D.B., and Wolf P. Nonspecific phosphodiesterase inhibition attenuates liver injury in acute endotoxemia. Surg. Infect. (Larchmt.) 6 (2005) 73
8. Coimbra R., Melbostad H., Loomis W., Porcides R.D., Wolf P., Tobar M., and Hoyt D.B. LPS-induced acute lung injury is attenuated by phosphodiesterase inhibition: effects on proinflammatory mediators, metalloproteinases, NF-kappaB, and ICAM-1 expression. J. Trauma 60 (2006) 115
9. Delgado M., Abad C., Martinez C., Juarranz M.G., Leceta J., Ganea D., and Gomariz R.P. PACAP in immunity and inflammation. Ann. N. Y. Acad. Sci. 992 (2003) 141
10. Sullivan G.W., and Linden J. Role of A(2A) adenosine receptors in inflammation. Drug Dev. Res. 45 (1998) 103
11. Naito M., Hasegawa G., Ebe Y., and Yamamoto T. Differentiation and function of Kupffer cells. Med. Electron Microsc. 37 (2004) 16
12. Emmanuilidis K., Weighardt H., Maier S., Gerauer K., Fleischmann T., Zheng X.X., Hancock W.W., Holzmann B., and Heidecke C.D. Critical role of Kupffer cell-derived IL-10 for host defense in septic peritonitis. J. Immunol. 167 (2001) 3919
13. Schneider C.P., Schwacha M.G., and Chaudry I.H. The role of interleukin-10 in the regulation of the systemic inflammatory response following trauma-hemorrhage. Biochim. Biophys. Acta 1689 (2004) 22
14. Warner A.E. Pulmonary intravascular macrophages. Role in acute lung injury. Clin. Chest Med. 17 (1996) 125
15. Dahle M.K., Overland G., Myhre A.E., Stuestol J.F., Hartung T., Krohn C.D., Mathiesen O., Wang J.E., and Aasen A.O. The phosphatidylinositol 3-kinase/protein kinase B signaling pathway is activated by lipoteichoic acid and plays a role in Kupffer cell production of interleukin-6 (IL-6) and IL-10. Infect. Immun. 72 (2004) 5704
16. Dahle M.K., Myhre A.E., Aasen A.O., and Wang J.E. Effects of forskolin on kupffer cell production of interleukin-10 and tumor necrosis factor alpha differ from those of endogenous adenylyl cyclase activators: possible role for adenylyl cyclase 9. Infect. Immun. 73 (2005) 7290
17. Mizuno K., Takahashi H.K., Iwagaki H., Katsuno G., Kamurul H.A., Ohtani S., Mori S., Yoshino T., Nishibori M., and Tanaka N. Beta2-adrenergic receptor stimulation inhibits LPS-induced IL-18 and IL-12 production in monocytes. Immunol. Lett. 101 (2005) 168
18. Strassmann G., Patil-Koota V., Finkelman F., Fong M., and Kambayashi T. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180 (1994) 2365
19. Brenner S., Prosch S., Schenke-Layland K., Riese U., Gausmann U., and Platzer C. cAMP-induced Interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation. J. Biol. Chem. 278 (2003) 5597
20. Platzer C., Meisel C., Vogt K., Platzer M., and Volk H.D. Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int. Immunol. 7 (1995) 517
21. Strassmann G., Patil-Koota V., Finkelman F., Fong M., and Kambayashi T. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180 (1994) 2365
22. Bernardin G., Strosberg A.D., Bernard A., Mattei M., and Marullo S. Beta-adrenergic receptor-dependent and-independent stimulation of adenylate cyclase is impaired during severe sepsis in humans. Intensive Care Med. 24 (1998) 1315
23. Bernardin G., Kisoka R.L., Delporte C., Robberecht P., and Vincent J.L. Impairment of beta-adrenergic signaling in healthy peripheral blood mononuclear cells exposed to serum from patients with septic shock: involvement of the inhibitory pathway of adenylyl cyclase stimulation. Shock 19 (2003) 108
24. Leeper-Woodford S.K., and Detmer K. Acute hypoxia increases alveolar macrophage tumor necrosis factor activity and alters NF-kappaB expression. Am. J. Physiol. 276 (1999) L909-L916
25. Defer N., Best-Belpomme M., and Hanoune J. Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase. AJP- Renal. Physiol. 279 (2000) F400-F416
26. Premont R.T., Matsuoka I., Mattei M.G., Pouille Y., Defer N., and Hanoune J. Identification and characterization of a widely expressed form of adenylyl cyclase. J. Biol. Chem. 271 (1996) 13900
27. Hacker B.M., Tomlinson J.E., Wayman G.A., Sultana R., Chan G., Villacres E., Disteche C., and Storm D.R. Cloning, chromosomal mapping, and regulatory properties of the human type 9 adenylyl cyclase (ADCY9). Genomics 50 (1998) 97
28. Geng W., Wang Z., Zhang J., Reed B.Y., Pak C.Y., and Moe O.W. Cloning and characterization of the human soluble adenylyl cyclase. Am. J. Physiol.: Cell Physiol. 288 (2005) C1305-C1316
29. Osawa Y., Lee H.T., Hirshman C.A., Xu D., and Emala C.W. Lipopolysaccharide-induced sensitization of adenylyl cyclase activity in murine macrophages. Am. J. Physiol.: Cell Physiol. 290 (2006) C143-C151
30. Taussig R., and Gilman A.G. Mammalian membrane-bound adenylyl cyclases. J. Biol. Chem. 270 (1995) 1
31. Fischer W., Schudt C., and Wendel A. Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice. Biochem. Pharmacol. 45 (1993) 2399
32. Hatherill J.R., Yonemaru M., Zheng H., Hoffmann H., Fujishima S., Ishizaka A., and Raffin T.A. Attenuation of acute lung injury in septic guinea-pigs by a new xanthine derivative (HWA-138). Pharmatherapeutica 5 (1989) 407
33. Ishizaka A., Wu Z.H., Stephens K.E., Harada H., Hogue R.S., O'Hanley P.T., and Raffin T.A. Attenuation of acute lung injury in septic guinea pigs by pentoxifylline. Am. Rev. Respir. Dis. 138 (1988) 376
34. Krysztopik R.J., Bentley F.R., Wilson M.A., Spain D.A., and Garrison R.N. Vasomotor response to pentoxifylline mediates improved renal blood flow to bacteremia. J. Surg. Res. 63 (1996) 17
35. Lilly C.M., Sandhu J.S., Ishizaka A., Harada H., Yonemaru M., Larrick J.W., Shi T.X., O'Hanley P.T., and Raffin T.A. Pentoxifylline prevents tumor necrosis factor-induced lung injury. Am. Rev. Respir. Dis. 139 (1989) 1361
36. Okano S., Tagawa M., Urakawa N., and Ogawa R. Effect of dibutyryl cyclic AMP on hemodynamics and chemical mediators in dogs with experimentally-induced endotoxic shock. J. Vet. Med. Sci. 55 (1993) 1001
37. Thomas N.J., Carcillo J.A., Herzer W.A., Mi Z., Tofovic S.P., and Jackson E.K. Type IV phosphodiesterase inhibition improves cardiac contractility in endotoxemic rats. Eur. J. Pharmacol. 465 (2003) 133
38. Yanase T., Enzan K., Mitsuhata H., and Horiguchi T. Dibutyryl cAMP improves systemic vasoconstriction caused by endotoxin in dogs. Shock 5 (1996) 284
39. Wang Y.Y., Dahle M.K., Agren J., Myhre A.E., Reinholt F.P., Foster S.J., Collins J.L., Thiemermann C., Aasen A.O., and Wang J.E. Activation of the liver X receptor protects against hepatic injury in endotoxemia by suppressing Kupffer cell activation. Shock 25 (2006) 141
40. Curnow R.T., Rayfield E.J., George D.T., Zenser T.V., and DeRubertis F.R. Altered hepatic glycogen metabolism and glucoregulatory hormones during sepsis. Am. J. Physiol. 230 (1976) 1296
41. Ghosh S., and Liu M.S. Decrease in adenylate cyclase activity in dog livers during endotoxic shock. Am. J. Physiol. 245 (1983) R737-R742
42. Goto F., Fujita T., Otani E., and Yamamuro M. The effect of indomethacin and adrenergic receptor blocking agents on rats and canine responses to endotoxin. Circ. Shock 7 (1980) 413
43. Hsu C., Hsu H.K., Yang S.L., Jao H.C., and Liu M.S. Liver protein kinase A activity is decreased during the late hypoglycemic phase of sepsis. Shock 12 (1999) 274
44. Romano F.D., and Jones S.B. Beta-adrenergic stimulation of myocardial cyclic AMP in endotoxic rats. Circ. Shock 17 (1985) 243
45. Wilson R.F. The pathophysiology of shock. Intensive Care Med. 6 (1980) 89
46. Okonogi K., Gettys T.W., Uhing R.J., Tarry W.C., Adams D.O., and Prpic V. Inhibition of prostaglandin E2-stimulated cAMP accumulation by lipopolysaccharide in murine peritoneal macrophages. J. Biol. Chem. 266 (1991) 10305
47. Han H., Stessin A., Roberts J., Hess K., Gautam N., Kamenetsky M., Lou O., Hyde E., Nathan N., Muller W.A., Buck J., Levin L.R., and Nathan C. Calcium-sensing soluble adenylyl cyclase mediates TNF signal transduction in human neutrophils. J. Exp. Med. 202 (2005) 353
48. Onda T., Hashimoto Y., Nagai M., Kuramochi H., Saito S., Yamazaki H., Toya Y., Sakai I., Homcy C.J., Nishikawa K., and Ishikawa Y. Type-specific regulation of adenylyl cyclase. Selective pharmacological stimulation and inhibition of adenylyl cyclase isoforms. J. Biol. Chem. 276 (2001) 47785
49. Gao M.H., Lai N.C., Roth D.M., Zhou J., Zhu J., Anzai T., Dalton N., and Hammond H.K. Adenylylcyclase increases responsiveness to catecholamine stimulation in transgenic mice. Circulation 99 (1999) 1618
50. Gao M.H., Bayat H., Roth D.M., Yao Z.J., Drumm J., Burhan J., and Hammond H.K. Controlled expression of cardiac-directed adenylylcyclase type VI provides increased contractile function. Cardiovasc. Res. 56 (2002) 197
51. Gao M.H., Tang T., Guo T., Sun S.Q., Feramisco J.R., and Hammond H.K. Adenylyl cyclase type VI gene transfer reduces phospholamban expression in cardiac myocytes via activating transcription factor 3. J. Biol. Chem. 279 (2004) 38797
52. Roth D.M., Bayat H., Drumm J.D., Gao M.H., Swaney J.S., Ander A., and Hammond H.K. Adenylyl cyclase increases survival in cardiomyopathy. Circulation 105 (2002) 1989
53. Okumura S., Takagi G., Kawabe J., Yang G.P., Lee M.C., Hong C., Liu J., Vatner D.E., Sadoshima J., Vatner S.F., and Ishikawa Y. Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 9986
54. Cioffi D.L., Moore T.M., Schaack J., Creighton J.R., Cooper D.M., and Stevens T. Dominant regulation of interendothelial cell gap formation by calcium-inhibited type 6 adenylyl cyclase. J. Cell Biol. 157 (2002) 1267
55. Sayner S.L., Alexeyev M., Dessauer C.W., and Stevens T. Soluble adenylyl cyclase reveals the significance of cAMP compartmentation on pulmonary microvascular endothelial cell barrier. Circ. Res. (2006)
56. Tantisira K.G., Small K.M., Litonjua A.A., Weiss S.T., and Liggett S.B. Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways. Hum. Mol. Genet. 14 (2005) 1671
57. Tinsley K.W., Grayson M.H., Swanson P.E., Drewry A.M., Chang K.C., Karl I.E., and Hotchkiss R.S. Sepsis induces apoptosis and profound depletion of splenic interdigitating and follicular dendritic cells. J. Immunol. 171 (2003) 909